Skip to main content
Search hero banner

Search results

Showing 81 - 100 of 137 results

CEO of Supply Nation Kate Russell, Acting/Deputy CEO of Kinaway Chamber of Commerce and ANSTO CEO Shaun Jenkinson will be exploring the importance of achieving supplier diversity in an online webinar. Many organisations want to do more in this sphere of activity to support Reconciliation but face challenges.
Online event
Nevena Kosarac
Past project member

Ms. Nevena Kosarac completed her honours thesis under the umbrella of this project at UNSW Sydney in 2021. Ms.

Beamtime Guide - X-ray Fluorescence Microscopy

Beamtime Guide - XFM

Beamtime Guide on the X-ray Fluorescence Microscopy beamline at the Australian Synchrotron.

Tina Paneras
Radiation Safety Training Educator

Tina is a Radiation Safety Training Educator within Radiation Services. She is responsible for the development, maintenance, and delivery of radiation safety courses to different facets of industry.

Feathery moa’s fossilised footprints, ancient age revealed

ANSTO scientist, Dr Klaus Wilcken of the Centre for Accelerator Science, used cosmogenic nuclide dating to determine the ages of layered sand and gravel samples, in which seven footprints of the flightless bird, the moa, were found on the South Island in New Zealand in 2019.

Governance at ANSTO

Governance

ANSTO is a highly regulated organisation. Our governance system and processes provide critical guidance to effectively manage ANSTO’s activities. This section outlines the processes and systems that are in place to provide assurance to Government, our stakeholders and the community that we are working within our regulated and mandated requirements.

Dr Robert Russell
Research Biochemist & Asset Manager, National Deuteration Facility

Role at ANSTO

Mitchell Timpano
Radioactive Waste Supervisor

Mitchell Timpano is a Radioactive Waste Supervisor leading the decontamination team in ANSTO’s Waste Management Services.

Advanced radiotherapy

Radiotherapy

The radiography program focuses on the development of Neutron Capture Enhanced Particle Therapy (NCEPT) from initial preclinical work, to clinical trials and finally commercial translation and licencing.

Pagination